🇺🇸 FDA
Patent

US 10335478

Avirulent, immunogenic flavivirus chimeras

granted A61KA61K2039/5254A61K2039/5256

Quick answer

US patent 10335478 (Avirulent, immunogenic flavivirus chimeras) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 27 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2039/5254, A61K2039/5256, A61K2039/53, A61K2039/70